Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1320-2015Class III

cobas EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay

Roche Molecular Systems Inc / initiated 2015-01-13 / Terminated

Roche Molecular Systems, Inc. began a recall of cobas EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay on . FDA classified it as Class III and gives the reason as "False positive results for Exon 20 insertion mutations are being detected with the cobas EGFR Mutation Test, kit batch T08661". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1320-2015
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Roche Molecular Systems Inc
Product
cobas EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay
Product code
OWD Somatic Gene Mutation Detection System
Reason for recall
False positive results for Exon 20 insertion mutations are being detected with the cobas EGFR Mutation Test, kit batch T08661.
FDA root cause
Under Investigation by firm
Action
RMS notified their customers on 1/13/2015.
Quantity in commerce
190 kits
Distribution
Foreign
Product codes and lots
T08661

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1320-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1320-2015Class IIITerminatedVoluntary: Firm initiated